Experimental Combination Chemotherapy: Intracarotid versus Intravenous Administration of Aziridinylbenzoquinone, BCNU, and Cisplatin in Dogs
العنوان: | Experimental Combination Chemotherapy: Intracarotid versus Intravenous Administration of Aziridinylbenzoquinone, BCNU, and Cisplatin in Dogs |
---|---|
المؤلفون: | L. C. Stephens, Sidney Wallace, Kenneth C. Wright, Lynn G. Feun, Niramol Savaraj |
المصدر: | Chemotherapy. 33:437-444 |
بيانات النشر: | S. Karger AG, 1987. |
سنة النشر: | 1987 |
مصطلحات موضوعية: | Lung Diseases, Male, Aziridines, Drug Evaluation, Preclinical, Antineoplastic Agents, Pharmacology, Route of administration, Dogs, Animal model, Antineoplastic Combined Chemotherapy Protocols, Drug Discovery, Benzoquinones, Animals, Infusions, Intra-Arterial, Medicine, Pharmacology (medical), Infusions, Intravenous, Lymphatic Diseases, Cisplatin, Carmustine, Diaziquone, business.industry, Combination chemotherapy, General Medicine, Carotid Arteries, Infectious Diseases, Oncology, Anesthesia, Toxicity, Female, Chemical and Drug Induced Liver Injury, business, medicine.drug |
الوصف: | Sixteen adult beagles (10-12 kg) were used to evaluate combinations of 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ, aziridinylbenzoquinone), 1,3-bis-2-chloroethyl-1-nitrosourea (BCNU, carmustine), and cis-dichlorodiammineplatinum(II) (CDDP, cisplatin) administered by intravenous or intracarotid infusion. Moderate to severe systemic toxicities resulted from all drug infusions, but no histopathologic changes were found in the central nervous system (CNS) of any of the dogs. Results indicated that the toxicities were not dependent on the route of administration or the recipient's gender, and they were reversible in most cases with intravenous supportive therapy. Cisplatin seemed to have an additive effect when administered in combination with AZQ and/or BCNU. |
تدمد: | 1421-9794 0009-3157 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bdb1e8ca71c092467b46b5eae975cfTest https://doi.org/10.1159/000238532Test |
حقوق: | CLOSED |
رقم الانضمام: | edsair.doi.dedup.....b1bdb1e8ca71c092467b46b5eae975cf |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....b1bdb1e8ca71c092467b46b5eae975cf 705 3 unknown 705.149597167969 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1bdb1e8ca71c092467b46b5eae975cf&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
|
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Experimental Combination Chemotherapy: Intracarotid versus Intravenous Administration of Aziridinylbenzoquinone, BCNU, and Cisplatin in Dogs
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22L%2E+C%2E+Stephens%22">L. C. Stephens</searchLink><br /><searchLink fieldCode="AR" term="%22Sidney+Wallace%22">Sidney Wallace</searchLink><br /><searchLink fieldCode="AR" term="%22Kenneth+C%2E+Wright%22">Kenneth C. Wright</searchLink><br /><searchLink fieldCode="AR" term="%22Lynn+G%2E+Feun%22">Lynn G. Feun</searchLink><br /><searchLink fieldCode="AR" term="%22Niramol+Savaraj%22">Niramol Savaraj</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>Chemotherapy</i>. 33:437-444 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => S. Karger AG, 1987. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 1987 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Lung+Diseases%22">Lung Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Aziridines%22">Aziridines</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Evaluation%2C+Preclinical%22">Drug Evaluation, Preclinical</searchLink><br /><searchLink fieldCode="DE" term="%22Antineoplastic+Agents%22">Antineoplastic Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology%22">Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22Route+of+administration%22">Route of administration</searchLink><br /><searchLink fieldCode="DE" term="%22Dogs%22">Dogs</searchLink><br /><searchLink fieldCode="DE" term="%22Animal+model%22">Animal model</searchLink><br /><searchLink fieldCode="DE" term="%22Antineoplastic+Combined+Chemotherapy+Protocols%22">Antineoplastic Combined Chemotherapy Protocols</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Discovery%22">Drug Discovery</searchLink><br /><searchLink fieldCode="DE" term="%22Benzoquinones%22">Benzoquinones</searchLink><br /><searchLink fieldCode="DE" term="%22Animals%22">Animals</searchLink><br /><searchLink fieldCode="DE" term="%22Infusions%2C+Intra-Arterial%22">Infusions, Intra-Arterial</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology+%28medical%29%22">Pharmacology (medical)</searchLink><br /><searchLink fieldCode="DE" term="%22Infusions%2C+Intravenous%22">Infusions, Intravenous</searchLink><br /><searchLink fieldCode="DE" term="%22Lymphatic+Diseases%22">Lymphatic Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Cisplatin%22">Cisplatin</searchLink><br /><searchLink fieldCode="DE" term="%22Carmustine%22">Carmustine</searchLink><br /><searchLink fieldCode="DE" term="%22Diaziquone%22">Diaziquone</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Combination+chemotherapy%22">Combination chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22General+Medicine%22">General Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Carotid+Arteries%22">Carotid Arteries</searchLink><br /><searchLink fieldCode="DE" term="%22Infectious+Diseases%22">Infectious Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22Anesthesia%22">Anesthesia</searchLink><br /><searchLink fieldCode="DE" term="%22Toxicity%22">Toxicity</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Chemical+and+Drug+Induced+Liver+Injury%22">Chemical and Drug Induced Liver Injury</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edrug%22">medicine.drug</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Sixteen adult beagles (10-12 kg) were used to evaluate combinations of 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ, aziridinylbenzoquinone), 1,3-bis-2-chloroethyl-1-nitrosourea (BCNU, carmustine), and cis-dichlorodiammineplatinum(II) (CDDP, cisplatin) administered by intravenous or intracarotid infusion. Moderate to severe systemic toxicities resulted from all drug infusions, but no histopathologic changes were found in the central nervous system (CNS) of any of the dogs. Results indicated that the toxicities were not dependent on the route of administration or the recipient's gender, and they were reversible in most cases with intravenous supportive therapy. Cisplatin seemed to have an additive effect when administered in combination with AZQ and/or BCNU. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1421-9794<br />0009-3157 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bdb1e8ca71c092467b46b5eae975cf" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bdb1e8ca71c092467b46b5eae975cf</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1159/000238532" linkWindow="_blank">https://doi.org/10.1159/000238532</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => CLOSED ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....b1bdb1e8ca71c092467b46b5eae975cf ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 8
[StartPage] => 437
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Lung Diseases
[Type] => general
)
[1] => Array
(
[SubjectFull] => Male
[Type] => general
)
[2] => Array
(
[SubjectFull] => Aziridines
[Type] => general
)
[3] => Array
(
[SubjectFull] => Drug Evaluation, Preclinical
[Type] => general
)
[4] => Array
(
[SubjectFull] => Antineoplastic Agents
[Type] => general
)
[5] => Array
(
[SubjectFull] => Pharmacology
[Type] => general
)
[6] => Array
(
[SubjectFull] => Route of administration
[Type] => general
)
[7] => Array
(
[SubjectFull] => Dogs
[Type] => general
)
[8] => Array
(
[SubjectFull] => Animal model
[Type] => general
)
[9] => Array
(
[SubjectFull] => Antineoplastic Combined Chemotherapy Protocols
[Type] => general
)
[10] => Array
(
[SubjectFull] => Drug Discovery
[Type] => general
)
[11] => Array
(
[SubjectFull] => Benzoquinones
[Type] => general
)
[12] => Array
(
[SubjectFull] => Animals
[Type] => general
)
[13] => Array
(
[SubjectFull] => Infusions, Intra-Arterial
[Type] => general
)
[14] => Array
(
[SubjectFull] => Medicine
[Type] => general
)
[15] => Array
(
[SubjectFull] => Pharmacology (medical)
[Type] => general
)
[16] => Array
(
[SubjectFull] => Infusions, Intravenous
[Type] => general
)
[17] => Array
(
[SubjectFull] => Lymphatic Diseases
[Type] => general
)
[18] => Array
(
[SubjectFull] => Cisplatin
[Type] => general
)
[19] => Array
(
[SubjectFull] => Carmustine
[Type] => general
)
[20] => Array
(
[SubjectFull] => Diaziquone
[Type] => general
)
[21] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[22] => Array
(
[SubjectFull] => Combination chemotherapy
[Type] => general
)
[23] => Array
(
[SubjectFull] => General Medicine
[Type] => general
)
[24] => Array
(
[SubjectFull] => Carotid Arteries
[Type] => general
)
[25] => Array
(
[SubjectFull] => Infectious Diseases
[Type] => general
)
[26] => Array
(
[SubjectFull] => Oncology
[Type] => general
)
[27] => Array
(
[SubjectFull] => Anesthesia
[Type] => general
)
[28] => Array
(
[SubjectFull] => Toxicity
[Type] => general
)
[29] => Array
(
[SubjectFull] => Female
[Type] => general
)
[30] => Array
(
[SubjectFull] => Chemical and Drug Induced Liver Injury
[Type] => general
)
[31] => Array
(
[SubjectFull] => business
[Type] => general
)
[32] => Array
(
[SubjectFull] => medicine.drug
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Experimental Combination Chemotherapy: Intracarotid versus Intravenous Administration of Aziridinylbenzoquinone, BCNU, and Cisplatin in Dogs
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => L. C. Stephens
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Sidney Wallace
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kenneth C. Wright
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lynn G. Feun
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Niramol Savaraj
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 1987
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 14219794
)
[1] => Array
(
[Type] => issn-print
[Value] => 00093157
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsair
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 33
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Chemotherapy
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |